Schubert & Co’s CONMED CNMD Stock Holding History

Schubert & Co’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12	Closed	-$1.25K	–	349
2023 Q1	$1.25K	Buy	12 +4	+50%	+$387	﹤0.01%	1105
2022 Q4	$709	Hold	8	–	–	﹤0.01%	1297
2022 Q3	$1K	Sell	8 -1	-11%	-$94	﹤0.01%	1044
2022 Q2	$1K	Buy	9 +4	+80%	+$480	﹤0.01%	1037
2022 Q1	$1K	Buy	5 +1	+25%	+$140	﹤0.01%	623
2021 Q4	$1K	Buy	+4	New	+$567	﹤0.01%	572

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Schubert & Co's CNMD Position: Q2 2023 in Review

Schubert & Co sold out of CONMED (CNMD) in Q2 2023, closing a stake of 12 shares — an estimated $1.25K sold.

Schubert & Co first reported a position in CNMD in Q4 2021 and held it in 6 quarters. The position peaked at $1.25K in Q1 2023. 263 funds tracked by Wall St. Rank hold CNMD as of Q2 2023.

Schubert & Co reported no remaining CONMED position as of Q2 2023 after selling out during the quarter.
Schubert & Co sold 12 CONMED shares in Q2 2023, an estimated $1.25K.
Schubert & Co first reported a position in CONMED in Q4 2021 and held it in 6 quarters.
Schubert & Co's CONMED position peaked at $1.25K in Q1 2023.
263 funds tracked by Wall St. Rank held CONMED as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.